A., Habener, J
Customers tell us they want peace of mind so that if a consumer has their beverage across multiple day parts, they will have a large margin before hitting tolerance levels. Why beverage brands need to brace themselves The thirst for GLP-1 medication only looks set to increase among consumers with the launch of unfussy, non-injectable formats A pill version of the appetite-suppressing drug, Wegovy, was unveiled by pharma giant Novo Nordisk in January Eli Lilly & Co is preparing to debut its own oral version, Orforglipron, post-FDA approval later this year The total GLP-1 pill market is forecast to leap from $3.2bn in 2025 to 34.3 bn in 2031, a CAGR of 48.4% (GlobalData) (Source GlobalData) GLP-1 drink NPD outside the box Although, its not just traditional food and beverage companies developing tailored NPD
Subcutaneous injection deposits the peptide into the fatty tissue layer just beneath the skin
Prescription and Administration If Tirzepatide is deemed suitable for your needs, your healthcare provider will prescribe the medication, and you will receive instructions on how to administer the shots
Exploring female infertility: a comprehensive review of polycystic ovary syndrome (PCOS) and its impact on reproductive health
What This Means for You If you're on a GLP-1 medication and you're feeling flat you're not imagining it
